BACKGROUND: This study was designed to evaluate the benefits of InVEST (Increased Velocity Specific to Task) training on limb power and mobility among mobility-limited older adults. METHODS: We conducted a single blinded, randomized controlled trial among 138 mobility-limited community-dwelling older adults, evaluating two 16-week supervised exercise programs. The intervention group participated in InVEST training, and the control group participated in the National Institute on Aging's (NIA) strength training program. Primary outcomes were changes in limb power per kilogram and mobility performance as measured by the Short Physical Performance Battery (SPPB). RESULTS: After 16 weeks, InVEST produced significantly greater improvements in limb power than NIA (p=.02). There was no significant difference in strength improvements. Both groups had significant changes in SPPB of greater than 1 unit. Self-reported function was also significantly improved in both groups. Differences between groups were not statistically different. In a post hoc analysis when participants were categorized by the manifestation of baseline leg velocity impairments (N=68), InVEST training produced effect size differences in SPPB that were clinically meaningful (SPPB Group x Time difference 0.73 units, p=.05). CONCLUSIONS: Among mobility-limited older adults, both NIA and InVEST produce robust changes in observed physical performance and self-reported function. These improvements were not meaningfully different by statistical or clinical criteria. Compared with NIA, InVEST training produced greater improvements in limb power and equivalent improvements in strength. Observed differences between NIA and InVEST based upon baseline leg impairment status are informative for futures studies.
RCT Entities:
BACKGROUND: This study was designed to evaluate the benefits of InVEST (Increased Velocity Specific to Task) training on limb power and mobility among mobility-limited older adults. METHODS: We conducted a single blinded, randomized controlled trial among 138 mobility-limited community-dwelling older adults, evaluating two 16-week supervised exercise programs. The intervention group participated in InVEST training, and the control group participated in the National Institute on Aging's (NIA) strength training program. Primary outcomes were changes in limb power per kilogram and mobility performance as measured by the Short Physical Performance Battery (SPPB). RESULTS: After 16 weeks, InVEST produced significantly greater improvements in limb power than NIA (p=.02). There was no significant difference in strength improvements. Both groups had significant changes in SPPB of greater than 1 unit. Self-reported function was also significantly improved in both groups. Differences between groups were not statistically different. In a post hoc analysis when participants were categorized by the manifestation of baseline leg velocity impairments (N=68), InVEST training produced effect size differences in SPPB that were clinically meaningful (SPPB Group x Time difference 0.73 units, p=.05). CONCLUSIONS: Among mobility-limited older adults, both NIA and InVEST produce robust changes in observed physical performance and self-reported function. These improvements were not meaningfully different by statistical or clinical criteria. Compared with NIA, InVEST training produced greater improvements in limb power and equivalent improvements in strength. Observed differences between NIA and InVEST based upon baseline leg impairment status are informative for futures studies.
Authors: J M Guralnik; L Ferrucci; C F Pieper; S G Leveille; K S Markides; G V Ostir; S Studenski; L F Berkman; R B Wallace Journal: J Gerontol A Biol Sci Med Sci Date: 2000-04 Impact factor: 6.053
Authors: Stephen M Haley; Alan M Jette; Wendy J Coster; Jill T Kooyoomjian; Suzette Levenson; Tim Heeren; Jacqueline Ashba Journal: J Gerontol A Biol Sci Med Sci Date: 2002-04 Impact factor: 6.053
Authors: Jonathan F Bean; Suzanne G Leveille; Dan K Kiely; Stephania Bandinelli; Jack M Guralnik; Luigi Ferrucci Journal: J Gerontol A Biol Sci Med Sci Date: 2003-08 Impact factor: 6.053
Authors: Jonathan Bean; Seth Herman; Dan K Kiely; Damien Callahan; Kelly Mizer; Walter R Frontera; Roger A Fielding Journal: J Am Geriatr Soc Date: 2002-04 Impact factor: 5.562
Authors: Jonathan F Bean; Seth Herman; Dan K Kiely; Ingrid C Frey; Suzanne G Leveille; Roger A Fielding; Walter R Frontera Journal: J Am Geriatr Soc Date: 2004-05 Impact factor: 5.562
Authors: Michelle M Ouellette; Nathan K LeBrasseur; Jonathan F Bean; Edward Phillips; Joel Stein; Walter R Frontera; Roger A Fielding Journal: Stroke Date: 2004-04-22 Impact factor: 7.914
Authors: Stephen P Sayers; Alan M Jette; Stephen M Haley; Tim C Heeren; Jack M Guralnik; Roger A Fielding Journal: J Am Geriatr Soc Date: 2004-09 Impact factor: 5.562
Authors: Nancy K Latham; Derrick A Bennett; Caroline M Stretton; Craig S Anderson Journal: J Gerontol A Biol Sci Med Sci Date: 2004-01 Impact factor: 6.053
Authors: Pradeep Suri; Dan K Kiely; Suzanne G Leveille; Walter R Frontera; Jonathan F Bean Journal: Arch Phys Med Rehabil Date: 2011-06-02 Impact factor: 3.966
Authors: Dylan R Kirn; Kieran F Reid; Cynthia Hau; Edward M Phillips; Roger A Fielding Journal: J Gerontol A Biol Sci Med Sci Date: 2015-11-18 Impact factor: 6.053
Authors: Poonam K Pardasaney; Pengsheng Ni; Mary D Slavin; Nancy K Latham; Robert C Wagenaar; Jonathan Bean; Alan M Jette Journal: Arch Phys Med Rehabil Date: 2014-03-28 Impact factor: 3.966
Authors: Xin Li; Daniel E Forman; Dan K Kiely; Sharon LaRose; Ronald Hirschberg; Walter R Frontera; Jonathan F Bean Journal: Arch Phys Med Rehabil Date: 2012-02 Impact factor: 3.966
Authors: Jacqueline Louise Mair; Luca Laudani; Giuseppe Vannozzi; Giuseppe De Vito; Colin Boreham; Andrea Macaluso Journal: Eur J Appl Physiol Date: 2014-02-07 Impact factor: 3.078
Authors: Mini E Jacob; Thomas G Travison; Rachel E Ward; Nancy K Latham; Suzanne G Leveille; Alan M Jette; Jonathan F Bean Journal: J Gerontol A Biol Sci Med Sci Date: 2019-03-14 Impact factor: 6.053